|
Ren Sun lab at UCLA |
|
University of California, Los Angeles |
|
16. Staskus KA, Sun R, Miller G, Racz P, Jaslowski A, Metroka C, Brett-Smith H, Haase AT. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol. 1999; 73(5):4181-7. [PubMed] 15. Sun R, Lin SF, Staskus K, Gradoville L, Grogan E, Haase A, Miller G. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J Virol. 1999; 73(3):2232-42. [PubMed] 14. Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, Miller G. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A. 1998; 95(18):10866-71. [PubMed] 13. Angeloni A, Heston L, Uccini S, Sirianni MC, Cottoni F, Masala MV, Cerimele D, Lin SF, Sun R, Rigsby M, Faggioni A, Miller G. High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia. J Infect Dis. 1998; 177(6):1715-8. [PubMed] 12. Qunibi W, Al-Furayh O, Almeshari K, Lin SF, Sun R, Heston L, Ross D, Rigsby M, Miller G. Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia. Transplantation. 1998; 65(4):583-5. [PubMed] 11. Spain TA, Sun R, Gradzka M, Lin SF, Craft J, Miller G. The transcriptional activator Sp1, a novel autoantigen. Arthritis Rheum. 1997; 40(6):1085-95. [PubMed] 10. Spain TA, Sun R, Miller G. The locus of Epstein-Barr virus terminal repeat processing is bound with enhanced affinity by Sp1 and Sp3. Virology. 1997; 237(1):137-47. [PubMed] 9. Sun R, Spain TA, Lin SF, Miller G. Sp1 binds to the precise locus of end processing within the terminal repeats of Epstein-Barr virus DNA. J Virol. 1997; 71(8):6136-43. [PubMed] 8. Lin SF, Sun R, Heston L, Gradoville L, Shedd D, Haglund K, Rigsby M, Miller G. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. J Virol. 1997; 71(4):3069-76. [PubMed] 7. Miller G, Heston L, Grogan E, Gradoville L, Rigsby M, Sun R, Shedd D, Kushnaryov VM, Grossberg S, Chang Y. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J Virol. 1997; 71(1):314-24. [PubMed] 6. Serio TR, Angeloni A, Kolman JL, Gradoville L, Sun R, Katz DA, Van Grunsven W, Middeldorp J, Miller G. Two 21-kilodalton components of the Epstein-Barr virus capsid antigen complex and their relationship to ZEBRA-associated protein p21 (ZAP21). J Virol. 1996; 70(11):8047-54. [PubMed] 5. Sun R, Lin SF, Gradoville L, Miller G. Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A. 1996; 93(21):11883-8. [PubMed] 4. Miller G, Rigsby MO, Heston L, Grogan E, Sun R, Metroka C, Levy JA, Gao SJ, Chang Y, Moore P. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med. 1996; 334(20):1292-7. [PubMed] 3. Sun R, Grogan E, Shedd D, Bykovsky AF, Kushnaryov VM, Grossberg SE, Miller G. Transmissible retrovirus in Epstein-Barr virus-producer B95-8 cells. Virology. 1995; 209(2):374-83. [PubMed] 2. Sun R, Spain TA, Lin SF, Miller G. Autoantigenic proteins that bind recombinogenic sequences in Epstein-Barr virus and cellular DNA. Proc Natl Acad Sci U S A. 1994; 91(18):8646-50. [PubMed] 1. Katz DA, Baumann RP, Sun R, Kolman JL, Taylor N, Miller G. Viral proteins associated with the Epstein-Barr virus transactivator, ZEBRA. Proc Natl Acad Sci U S A. 1992; 89(1):378-82. [PubMed] |
|
Publications |
